22/04/2021 - General information
Dr. Anna Bigas, coordinator of the Stem cells and cancer Research Group of the Hospital del Mar Medical Research Institute (IMIM) and scientific director of the CIBER Oncology has been chosen one of the Top 100 Women Leaders in Spain.
This is a ranking created by Mujeres & Cia in 2011, an online magazine of reference among professional women that aims to make female talent visible and build a society based on equality.
On the afternoon of April 21, the Top 100 Gala was held, this year in hybrid format, which was attended by Nadia Calviño, Second Vice President of the Government, soprano Pilar Navarro and TV presenter Sonsoles Onega. At the event, the chosen ones were announced, including Dr. Anna Bigas in the category of Academics, researchers and thinkers. Of the 100 chosen, 50 are chosen by a jury, 40 by Mujeres & Cia and 10 by the public through voting.
This is the 9th edition of the initiative in which the number of participants increases every year as well as the repercussion in the media, managing to put professional women, experts in different areas and talented in the focus of attention. This year, 500 candidates took part, there were about 70,000 votes and so far about 5,000 women have been visible among candidates and chosen
Dr. Bigas is the coordinator of the IMIM Stem cells and cancer Research Group, the Deputy Director of Preclinical Research at the Josep Carreras Leukaemia Research Institute and Scientific Director of the CIBER of Oncology (CIBERONC), her research is based on by studying how stem cells that keep different tissues in physiological conditions are generated and renewed. These processes have great similarities with those used by tumors for their perpetuation. It mainly focuses on the hematopoietic system and the process of leukemia.
This distinction helps to promote the visibility of women in all areas and offers social and media recognition to those chosen.
Dr. Anna Bigas. Source: IMIM:
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
